Live from the NIH registry
Studies recruiting near Mobile right now
Top 25 of 170 recruiting studies, sorted by proximity — each links to its official registry page
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
University of South Alabama Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Southern Cancer Center Pc — Daphne, Alabama (13.7 mi)
· Sponsor: Bristol-Myers Squibb
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Cancer, Metastatic, Cancer
N/A
Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Mobile, Alabama (4.5 mi)
· Sponsor: Massive Bio, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Southern Cancer Center — Daphne, Alabama (13.7 mi)
· Sponsor: SCRI Development Innovations, LLC
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Rhinovirus Infection
Phase 2
Interventional 180 participants sought
Velocity Clinical Research - Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Altesa Biosciences, Inc.
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: Mercy Health Ohio
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 160 — Mobile, Alabama (4.5 mi)
· Sponsor: Merus B.V.
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Local Institution - 0487 — Mobile, Alabama (4.5 mi)
· Sponsor: Bristol-Myers Squibb
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
USA Health Allen Cox Building — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Tricuspid Valve Disease
N/A
Interventional 78 participants sought
Springhill Memorial Hospital — Mobile, Alabama (4.5 mi)
· Sponsor: Corvivo Cardiovascular, Inc.
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
AMR Clinical — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Paroxysmal Atrial Fibrillation
N/A
Observational 250 participants sought
Mobile Cardiology Associates — Mobile, Alabama (4.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Eastern Shore Research Group — Fairhope, Alabama (16.6 mi)
· Sponsor: Boehringer Ingelheim
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Alliance for Multispecialty Research - Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: pH-D Feminine Health LLC
MYLUNG Consortium Part 3: Observational Study
Carcinoma, Non-Small-Cell Lung
N/A
Observational 7,500 participants sought
Southern Cancer Center, PC — Daphne, Alabama (13.7 mi)
· Sponsor: US Oncology Research
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Mobile Heart USA Health Cardiology Clinic — Mobile, Alabama (4.5 mi)
· Sponsor: Novo Nordisk A/S
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
Lipoprotein(a)
Phase 2
Interventional 750 participants sought
AMR Clinical Mobile ( Site 0149) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: PedAL BCU, LLC
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Viral Lung Infection and Acute Respiratory Failure
Phase 3
Interventional 3,527 participants sought
Research Site — Mobile, Alabama (4.5 mi)
· Sponsor: AstraZeneca
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Infirmary Cancer Care ( Site 0001) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sickle Cell Disease
Phase 3
Interventional 510 participants sought
Univer South Alabama Ped/Onc — Mobile, Alabama (4.5 mi)
· Sponsor: Novo Nordisk A/S
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
Waldenstrom Macroglobulinemia
N/A
Observational 111 participants sought
South Alabama Medical Science Foundation Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: BeiGene
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
USA Mitchell Cancer Institute ( Site 0014) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Mobile, Alabama (4.5 mi)
· Sponsor: AstraZeneca